The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
暂无分享,去创建一个
B. Pulendran | G. Shaw | A. Ward | E. Hunter | M. V. van Gils | C. Cottrell | R. Amara | Antu K Dey | Sailaja Gangadhara | Samantha L. Burton | T. Charles | P. Arunachalam | V. S. Bollimpelli | L. M. Sewall | C. Derdeyn
[1] B. Pulendran,et al. 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates , 2020, Science Immunology.
[2] Bertrand Z. Yeung,et al. T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers , 2020, Nature Medicine.
[3] D. Burton,et al. Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques , 2020, Cell reports.
[4] D. Burton,et al. Mapping polyclonal antibody responses in non-human primates vaccinated with HIV Env trimer subunit vaccines , 2019, bioRxiv.
[5] D. Burton,et al. HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite , 2019, Science Advances.
[6] John P. Moore,et al. Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes , 2019, Journal of Virology.
[7] Daniel W. Kulp,et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance , 2018, Cell.
[8] B. Pulendran,et al. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants , 2019, Journal of Virology.
[9] E. Karita,et al. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120 , 2019, Front. Immunol..
[10] Daniel W. Kulp,et al. Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers , 2019, Immunity.
[11] Andrew B. Ward,et al. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes , 2018, Journal of Virology.
[12] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[13] Bette Korber,et al. Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth , 2018, Cell reports.
[14] John R Yates,et al. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer , 2018, Nature Communications.
[15] D. Burton,et al. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization , 2018, Immunity.
[16] David J. Harvey,et al. Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen , 2018, Cell reports.
[17] R. Wyatt,et al. Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies , 2018, Front. Immunol..
[18] Iñaki Sanz,et al. BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data , 2018, Genome Medicine.
[19] B. Pulendran,et al. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques , 2018, PLoS pathogens.
[20] Daniel W. Kulp,et al. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding , 2017, Nature Communications.
[21] Daniel W. Kulp,et al. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches , 2017, Immunity.
[22] John P. Moore,et al. Native‐like Env trimers as a platform for HIV‐1 vaccine design , 2017, Immunological reviews.
[23] E. Karita,et al. Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth , 2016, PLoS pathogens.
[24] John P. Moore,et al. Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C , 2016, PLoS pathogens.
[25] Bryan Briney,et al. Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. , 2016, Cell reports.
[26] C. Soto,et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody , 2016, Science.
[27] R. Sanders,et al. HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies , 2016, Expert review of vaccines.
[28] E. Hunter,et al. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses , 2015, Proceedings of the National Academy of Sciences.
[29] G. Debnath,et al. D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .
[30] B. Pulendran,et al. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope , 2015, Journal of Virology.
[31] Daniel W. Kulp,et al. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site , 2015, PLoS pathogens.
[32] John P. Moore,et al. A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene , 2015, Journal of Virology.
[33] B. Moss,et al. CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge , 2014, Journal of Virology.
[34] J. Mascola,et al. Single-Cell and Deep Sequencing of IgG-Switched Macaque B Cells Reveal a Diverse Ig Repertoire following Immunization , 2014, The Journal of Immunology.
[35] Åsa K. Björklund,et al. Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.
[36] Jaap Heringa,et al. HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity , 2013, Retrovirology.
[37] John P. Moore,et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.
[38] Anurag Sethi,et al. Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth , 2013, PLoS pathogens.
[39] C. Sundling,et al. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. , 2012, Journal of immunological methods.
[40] C. A. Derdeyn,et al. B-Lymphocyte Dysfunction in Chronic HIV-1 Infection Does Not Prevent Cross-Clade Neutralization Breadth , 2012, Journal of Virology.
[41] A. Sethi,et al. The B Cell Response Is Redundant and Highly Focused on V1V2 during Early Subtype C Infection in a Zambian Seroconverter , 2010, Journal of Virology.
[42] S. Gnanakaran,et al. Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection. , 2010, Virology.
[43] S. Plotkin. Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.
[44] Bing Li,et al. Nonpathogenic Simian Immunodeficiency Virus Infection of Sooty Mangabeys Is Not Associated with High Levels of Autologous Neutralizing Antibodies , 2010, Journal of Virology.
[45] Thomas D. Goddard,et al. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. , 2010, Journal of structural biology.
[46] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[47] S. Gnanakaran,et al. Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways , 2009, PLoS pathogens.
[48] T. Kepler,et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. , 2009, Journal of virological methods.
[49] S. Gnanakaran,et al. Unique Mutational Patterns in the Envelope α2 Amphipathic Helix and Acquisition of Length in gp120 Hypervariable Domains Are Associated with Resistance to Autologous Neutralization of Subtype C Human Immunodeficiency Virus Type 1 , 2007, Journal of Virology.
[50] F. Bibollet-Ruche,et al. Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection , 2007, Journal of Virology.
[51] Xiping Wei,et al. Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[52] Anchi Cheng,et al. Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.
[53] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[54] Bette T. Korber,et al. Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission , 2004, Science.